Home > Back to Publisher > Report Information

Molecular Diagnostics in China

Kalorama Premium In Vitro Diagnostic Database
February 1, 2008
70 Pages - SKU: KLID1646608

Abstract Table of Contents Search inside this report Related Reports

Countries covered: China

Published in cooperation with McEvoy and Farmer. Not part of any Kalorama Information subscription packages. Due to license restrictions, not available on aggregated services.
For 12+ years, the team of Carl McEvoy and Michael Farmer have conducted exhaustive on-the-ground research in Asia, and most notabably China, interviewing lab employees and executives to obtain an accurate picture of the IVD market in China and other countries. In cooperation with Kalorama Information this report Molecular Diagnostics in China, is the definitive measure of PCR testing in China.

A high volume of PCR testing is peformed in China, with thousands of hospital labs performing tests. From 2000 to 2004, the PCR market in China nearly doubled. Growth rate has moderated substantially to 10-15% in the last couple of years. Those watching the Chinese IVD markets will find this to be a critical resource with the following information:

A Review of Developments in Chinese IVD
Markets for Molecular Diagnostics in China
Instrument and Reagent Segments
Government Activity Related to PCR Testing
Market Share of Major Players
Company Profiles

Information in the report is taken from Kalorama Inforamtion's edition of McEvoy and Farmer's Clinical Diagnostics in China, Market Summary and Participant Directory.

Customers seeking market information for the entire Chinese IVD Market across categories should purchase that publication.

TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY

What’s New in China

Molecular Diagnostics in China

Company Profiles

A Note on Names and Spelling

Abbreviations Used in This Report

CHAPTER TWO: COUNTRY SUMMARY

What’s New in China

The Healthcare System in China

Privatization

Private and Reference Laboratories

Private Medical Practice

Medical Insurance

A Brief Guide to the Bureaucracy

Product Registration

The “Clean” Campaign

Reimbursement

Tenders

Reagent Rental

Quality Control

Vacuum Tube Conversion

Consolidated Work Stations and Sample Automation

Second-hand Instruments

CHAPTER THREE: MARKET ANALYSIS

Commentary

Market Leaders

Pricing and Reimbursement

Quality Issues

Other Molecular Products

International Companies

CHAPTER FOUR: COMPANY PROFILES

Abbott Laboratories

Applied Biosystems

Amplly

Bioer Technology

Bio-Hema

BioMérieux (France)

Bayer HealthCare (US)

Da An Gene

Elikan Biological Technology

Fosun Diagnostics

Gene Company

Haoyuan Biotechnology

HealthDigit

Intec Products

Kehua Biotech

Lengguang Technology

Promega (US)

PG (PiGi)

Qiagen

Roche

Sciarray Biotech

Science International/Science Laboratories

Sino-American Biotechnology Company

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Exhibit 1: Chinese IVD Market, 1996-2006

Exhibit 2: Chinese Molecular Diagnostics Market, 2006

CHAPTER TWO: COUNTRY SUMMARY

Exhibit 3: Hospitals in China by Level (Level I, II, III, A, B, C and Unrated)

Exhibit 4 Hospitals in China by Number of Beds

CHAPTER THREE: MARKET ANALYSIS

Exhibit 6: Reagent Sales in China (Infectious Disease, Other)

Exhibit 7: Instrument Sales in China (Units Placed, Units Rented, Units Sold, Average Price)

Exhibit 8: Molecular Diagnostics in China

Exhibit 9: Reagent Market in China by Category (Kinetic/QPCR, Traditional, Other)

Exhibit 10: Instruments in China by Category (End Point, Kinetic)

Exhibit 11: Market Leaders

Exhibit 12: Average Price Lists for PCR Tests

Exhibit 13: Key Analytes (Analyte, Market Share)

Exhibit 14: Reimbursement Range for Kinetic Molecular Testing

Exhibit 15: Molecular Testing Distribution Companies

More China Molecular Diagnostics Reports

China Molecular Diagnostic by General Biologic Group Ltd.
China Molecular diagnostics in a high growth, high profit, high investment area in China. Industry players, investors, buyers, and vendors will benefit from this essential ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>

Molecular Diagnostics in China

Share this report

Other tasks

Research Assistance

Related Markets

Molecular Diagnostics Reports

Free Alert Me service